Fermenta Biotech Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: FERMENTA BSE: 506414

₹549.70

Sept. 30, 2026 · NSE · nse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #83 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Sun Pharmaceutical Industries Limited	435,863	146.5	13.7%	11.0%	—	72	8	30
Divi's Laboratories Limited	246,660	83.9	15.3%	62.7%	0.32%	70	4	51
Torrent Pharmaceuticals Limited	162,454	78.2	12.2%	34.6%	0.79%	56	0	31
Zydus Lifesciences Limited	115,910	33.3	17.3%	17.2%	0.09%	74	24	84
Cipla Limited	108,736	35.4	11.2%	-11.0%	0.97%	73	29	62
Laurus Labs Limited	106,969	122.5	17.1%	127.1%	—	78	24	53
Mankind Pharma Limited	103,406	47.4	11.7%	2.6%	—	68	12	86
Dr. Reddy's Laboratories Limited	102,916	154.7	10.9%	-0.9%	—	62	33	71
Fermenta Biotech Limited (this stock)	1,618	25.2	15.2%	—	0.68%	78	39	85

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value

₹1,718 Cr

EV / EBITDA

14.5x

EV / Sales

3.88x

Market cap / Sales

3.65x

Earnings yield

3.97%

Quarterly Financials

Download CSV

Standalone Consolidated

↓ Negative

Quarterly Revenue

Jun 2026 quarterly revenue is Rs 117 Cr, down 8.7% YoY.

↓ Negative

Quarterly Net Profit

Jun 2026 quarterly net profit is Rs 15 Cr, down 7.7% YoY.

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	112	20	15	₹5.2300
March 31, 2026	110	29	22	₹7.4900
Dec. 31, 2025	114	17	12	₹4.0400
Sept. 30, 2025	107	21	15	₹5.0500
June 30, 2025	119	23	16	₹5.5700
March 31, 2025	122	28	—	₹10.0500
Dec. 31, 2024	146	42	35	₹12.0470
Sept. 30, 2024	90	9	8	₹2.8100
June 30, 2024	73	-5	-5	₹-1.6800
March 31, 2024	90	1	-7	₹-2.5100
Dec. 31, 2023	89	18	12	₹4.0500
Sept. 30, 2023	51	-28	-28	₹-9.6900
June 30, 2023	77	5	5	₹1.6600

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23
Total income (before exceptional items)	117	116	118	113	128	126	148	92	75	91	92	53	79
Operating revenue	112	110	114	107	119	122	146	90	73	90	89	51	77
Other income	5	6	3	6	9	4	2	3	3	1	3	2	2
Operating expenses	89	88	91	84	96	89	96	74	71	81	63	63	64
Operating profit	23	22	23	23	23	33	50	15	2	9	26	-12	13
Operating profit margin	20.5%	19.9%	20.5%	21.4%	18.9%	26.8%	34.3%	17.3%	2.5%	10.0%	29.7%	-22.6%	17.2%
Depreciation	5	5	5	5	6	6	6	6	6	6	6	6	6
Interest	3	3	3	3	3	3	4	4	3	3	5	4	5
Exceptional items, gain / (loss)	—	9	-2	—	—	—	—	—	—	—	—	-9	—
Profit before tax	20	29	17	21	23	28	42	9	-5	1	18	-28	5
Tax	5	8	5	6	6	-1	7	1	—	8	6	—	—
Net profit	15	22	12	15	16	—	35	8	-5	-7	12	-28	5
EPS	5.23	7.49	4.04	5.05	5.57	10.05	12.05	2.81	-1.68	-2.51	4.05	-9.69	1.66
Net profit (TTM)	63	64	—	—	—	—	31	8	-28	-19	-13	-84	-54
EPS (TTM)	21.81	22.15	24.71	32.72	30.48	23.23	10.67	2.67	-9.83	-6.49	-4.59	-29.08	-18.65

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Total income (before exceptional items)	—	4.6%	474^†	442^†	315^†	—	395^†	379^†	236^†	20^†	13^†	—
Operating revenue	11.0%	3.8%	450^†	431^†	307^†	329^†	388^†	373^†	225^†	19^†	12^†	6^†
Other income	—	—	24^†	12^†	8^†	—	8^†	7^†	11^†	0^†	1^†	—
Operating expenses	—	—	359^†	330^†	270^†	290^†	312^†	279^†	180^†	26^†	22^†	10^†
Operating profit	32.8%	-0.6%	91^†	100^†	37^†	39^†	76^†	94^†	45^†	-6^†	-10^†	-4^†
Operating profit margin	—	—	20.2%^†	23.3%^†	12.0%^†	11.8%^†	19.6%^†	25.1%^†	19.9%^†	-32.2%^†	-77.4%^†	-58.8%^†
Depreciation	—	—	21^†	23^†	24^†	25^†	24^†	19^†	12^†	4^†	4^†	3^†
Interest	—	—	11^†	14^†	17^†	21^†	17^†	18^†	18^†	16^†	11^†	7^†
Exceptional items, gain / (loss)	—	—	7^†	0^†	-9^†	-60^†	0^†	0^†	0^†	0^†	0^†	0^†
Profit before tax	—	7.1%	89^†	74^†	-5^†	-59^†	43^†	63^†	25^†	-26^†	-23^†	5^†
Tax	—	—	25^†	—	—	-1^†	12^†	11^†	-22^†	—	—	0^†
Net profit	—	4.3%	64^†	—	-19^†	-58^†	30^†	52^†	47^†	-3^†	-24^†	5^†
EPS	—	4.2%	22.15^†	23.23^†	-6.49^†	-19.94^†	10.48^†	18.01^†	37.42^†	—	—	—

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Operating margin	20.2%^†	23.3%^†	12.0%^†	11.8%^†	19.6%^†	25.1%^†	19.9%^†	-32.2%^†	-77.4%^†	-58.8%^†
EBIT margin	22.4%^†	20.6%^†	4.1%^†	-11.5%^†	15.4%^†	21.8%^†	19.4%^†	-50.1%^†	-104.0%^†	200.4%^†
PBT margin	19.8%^†	17.3%^†	-1.5%^†	-17.8%^†	11.0%^†	17.0%^†	11.2%^†	-132.5%^†	-190.2%^†	82.3%^†
Net margin	14.3%^†	—	-6.1%^†	-17.5%^†	7.8%^†	13.9%^†	21.1%^†	-13.8%^†	-195.8%^†	76.9%^†
Interest coverage	8.77x^†	6.24x^†	0.73x^†	-1.80x^†	3.47x^†	4.50x^†	2.36x^†	-0.61x^†	-1.21x^†	1.70x^†
Dividend payout	0.0%^†	0.0%^†	—	—	0.0%^†	0.0%^†	0.0%^†	—	—	—
Earnings retention	100.0%^†	100.0%^†	—	—	100.0%^†	100.0%^†	100.0%^†	—	—	—
Current ratio	1.88x	1.62x	—	—	—	—	—	—	—	—
Quick ratio	1.20x	1.14x	—	—	—	—	—	—	—	—
Debt to equity	0.26x	0.29x	—	—	—	—	—	—	—	—
Return on equity	15.2%^†	—	—	—	—	—	—	—	—	—
Return on assets	9.9%^†	—	—	—	—	—	—	—	—	—
Return on capital employed	21.9%^†	20.9%^†	—	—	—	—	—	—	—	—
Asset turnover	0.69x^†	0.69x^†	—	—	—	—	—	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
March 31, 2026	93	-43	-42	30	62
March 31, 2025	34	0	-51	22	12

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
March 31, 2026	652	423	408	101	8	360	191	9	206	131
March 31, 2025	622	380	365	94	15	321	198	18	210	94

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.